|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:accreditation
|
ISO_certified
GMP_certified
|
|
gptkbp:acquisition
|
China_National_Pharmaceutical_Group_(2016)
|
|
gptkbp:businessModel
|
vertical integration
|
|
gptkbp:CEO
|
gptkb:Liang_Wannian
|
|
gptkbp:clinicalTrials
|
Phase III
vaccine efficacy
public health studies
multiple vaccine candidates
published studies
|
|
gptkbp:collaborations
|
international health organizations
|
|
gptkbp:community
|
local health programs
|
|
gptkbp:communityEngagement
|
health initiatives
|
|
gptkbp:communityPartnerships
|
international suppliers
|
|
gptkbp:corporateSocialResponsibility
|
healthcare_access
|
|
gptkbp:distribution
|
pharmaceutical products
|
|
gptkbp:employees
|
over 100,000
|
|
gptkbp:financialPerformance
|
strong growth
|
|
gptkbp:founded
|
2003
|
|
gptkbp:globalPresence
|
over 100 countries
|
|
gptkbp:headquarters
|
gptkb:Beijing,_China
|
|
gptkbp:healthcare
|
integrated healthcare services
pandemic response efforts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sinopharm Group
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:innovation
|
new drug development
|
|
gptkbp:investmentFocus
|
biotechnology companies
healthcare_technology
|
|
gptkbp:market
|
global
emerging markets
pharmaceutical_industry_in_China
|
|
gptkbp:marketShare
|
leading_in_China
|
|
gptkbp:notable_player
|
gptkb:COVID-19_vaccine
COVID-19 vaccines
|
|
gptkbp:parentCompany
|
gptkb:China_National_Pharmaceutical_Group
|
|
gptkbp:partnerships
|
gptkb:World_Health_Organization
local distributors
|
|
gptkbp:philanthropy
|
healthcare_donations
|
|
gptkbp:productLine
|
vaccines, therapeutics
|
|
gptkbp:products
|
vaccines
new vaccines
|
|
gptkbp:regulatoryCompliance
|
international standards
various countries
|
|
gptkbp:researchAndDevelopment
|
biopharmaceuticals
|
|
gptkbp:researchInterest
|
collaborations with universities
|
|
gptkbp:revenue
|
over $30 billion (2020)
|
|
gptkbp:stockExchange
|
gptkb:Hong_Kong_Stock_Exchange
|
|
gptkbp:stockSymbol
|
1099.HK
|
|
gptkbp:strategicGoals
|
biopharma companies
global health improvement
|
|
gptkbp:subsidiary
|
gptkb:China_National_Pharmaceutical_Group_Corporation
|
|
gptkbp:supplyChain
|
efficient logistics
pharmaceutical supply chain
|
|
gptkbp:sustainability
|
environmental initiatives
|